About Zosano Pharma
Zosano Pharma is a company based in Fremont (United States) founded in 2006. It operates as a B2B. Zosano Pharma has raised $147.16 million across 13 funding rounds from investors including Nomura, Trinity Cap and HBM Healthcare Investments. The company has 40 employees as of December 31, 2021. Zosano Pharma operates in a competitive market with competitors including Kriya Therapeutics, Sana Biotechnology, Semma Therapeutics, Cellino and Adocia, among others.
- Headquarter Fremont, United States
- Employees 40 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Zosano Pharma Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$147.16 M (USD)
in 13 rounds
-
Latest Funding Round
$14 M (USD), Debt – Venture
Sep 27, 2018
-
Investors
Nomura
& 5 more
-
Employee Count
40
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Zosano Pharma
Unlock access to complete
Funding Insights of Zosano Pharma
Zosano Pharma has successfully raised a total of $147.16M across 13 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $14 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Zosano Pharma
Zosano Pharma has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Nomura, Trinity Cap and HBM Healthcare Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt and equipment financing are provided to growth-stage companies.
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked |
Investor details for Zosano Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zosano Pharma
Investment portfolio details for Zosano Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zosano Pharma
Detailed financials for Zosano Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zosano Pharma Comparisons
Peer comparison for Zosano Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zosano Pharma
Zosano Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Sana Biotechnology, Semma Therapeutics, Cellino and Adocia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| Locked | Locked | Locked |
Developer of autologous cell therapies
|
|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Pendulum is focused on developing advanced probiotic solutions.
|
Detailed competitors of Zosano Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zosano Pharma
Complete news archive for Zosano Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zosano Pharma
Zosano Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Zosano Pharma is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Zosano Pharma is a funded company, having raised a total of $147.16M across 13 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Zosano Pharma is 40.
Zosano Pharma develops innovative transdermal drug delivery technologies for various therapeutic applications through providing healthcare solutions, producing pharmaceutical products, drug delivery, and transdermal systems. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Zosano Pharma's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
Zosano Pharma has 6 investors. Key investors include Nomura, Trinity Cap, HBM Healthcare Investments, Aisling Capital, and NEA.